Vir Biotechnology, Inc. Earnings Per Share Diluted

Quick Answer

Vir Biotechnology, Inc. reported Earnings Per Share Diluted of $3.16 (loss) per share for the year ending 2025.

  • Vir Biotechnology, Inc. showed an increase of +17.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Vir Biotechnology, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), Vir Biotechnology, Inc.'s Earnings Per Share Diluted has grown by 45.1%.
  • Historical annual values: Fiscal year 2025: $3.16 (loss) per share | Fiscal year 2024: $3.83 (loss) per share | Fiscal year 2023: $4.59 (loss) per share | Fiscal year 2022: $3.83 per share | Fiscal year 2021: $3.96 per share | Fiscal year 2020: $2.51 (loss) per share | Fiscal year 2019: $5.76 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: